GLUCOSYLCERAMID-SYNTHASE-HEMMER

European patent · EP3079695 · In force

Register entry

Publication number
EP3079695
Application number
EP14824245
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 9, 2014
Published
Oct 19, 2016
Granted
Mar 17, 2021
Protection ends at the latest
Dec 8, 2034
Next annual fee due
Dec 31, 2026
IPC classes
A61K 31/439 (2006.01)
A61P 9/00 (2006.01)
Priority
US 201361914842 P 11.12.2013
PCT application
PCT/US2014/069338 09.12.2014
PCT publication
WO2015/089067 18.06.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Jan 26, 2022

    Change

    Published in Swissreg on 26.01.2022

  6. Mar 17, 2021

    Granted

    Published in Swissreg on 17.03.2021

Parties

Inventor

ORSINI, Cécile

F-75008 Paris, FR

RET-LECUELLE, Gwénaëlle

F-75008 Paris, FR

DELEUZE, Jean-François

F-75008 Paris, FR

VIALE, Sandra

F-75008 Paris, FR

LEONARD, John P.

Bridgewater, New Jersey 08807, US

ITIER, Jean-Michel

F-75008 Paris, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.